1-3 of 3
Camille Montersino
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Deciphering EZH2 Non-Canonical Activities in AML Resistance

Lia N'guyen, Emeline Boet, Camille Montersino, Claire Burny, Stéphane Audebert, Luc Camoin, Rémy Castellano, Sylvain Garciaz, Atsushi Iwama, Jean-Emmanuel Sarry, Estelle Duprez, Mathilde Poplineau
Journal: Blood
Blood (2024) 144 (Supplement 1): 4097.
https://doi.org/10.1182/blood-2024-200580
Published: 2024
Journal Articles

Dasatinib Overcomes AML Resistance to BCL2 Inhibition By Indirectly Inhibiting MCL1: From Ex Vivo drug Sensitivity/Resistance Profiling to a Phase II Clinical Trial: A Hemato-BIO Study

Sylvain Garciaz, Rémy Castellano, Arnaud Jacquel, Arnaud Guille, Maxence Bourgoin, Camille Montersino, José Adélaïde, Patrick Auberger, Daniel Birnbaum, Marie Anne Hospital, Yves Collette, Norbert Vey
Journal: Blood
Blood (2024) 144 (Supplement 1): 1378.
https://doi.org/10.1182/blood-2024-207352
Published: 2024
Journal Articles

Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients

Norbert Vey, MD PhD, Marie Anne Hospital, Aude Collignon, Yves Collette, Daniel Birnbaum, Aude Charbonnier, Bilal Mohty, MD, Evelyne D'Incan, Jerome Rey, Remy Castellano, Camille Montersino, Max Chaffanet, Nadine Carbuccia, Jose Adelaide, Benjamin Bouchacourt, Arnaud Guille
Journal: Blood
Blood (2018) 132 (Supplement 1): 1401.
https://doi.org/10.1182/blood-2018-99-119263
Published: 2018